|
⚲
|
| Keyboard |
| Ancora 2030 V1 a sub-fund of Ancora ICAV | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002162876 |
| Sale | 2026-10-14 (1.0 M Sold) |
| Fund | Other Private Fund |
| Phone | 00442075696749 |
| Address | Pembroke Hall Dublin, L2 2 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-10-30 (D) |
| Exemption | 506(b) |
| Minimum | $125,000 |
| Remaining | Indefinite |
| Duration | More than one year |
| Commission | $14,000 |
| Net Assets | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Deirdre MC Grath | Director | |
| Jamie Lewis | Director | |
| Helen Maher | Director | |
| Conor Gilsenan | Director | |
| Anthony Duyck | Director |
| Comparable Firms | State | AUM |
|---|---|---|
|
Quilter Cheviot Europe Ltd
✚
|
L2 | |
|
National Bank of Canada Global Finance
✚
|
L2 | |
|
Irish Life Investment Managers Ltd
✚
|
L2 | |
|
Lansdowne Lothbury Master Fund Ltd
✚
|
L2 | |
|
Setanta Asset Management
✚
|
L2 | |
|
NBC Global Finance Ltd
✚
|
L2 | |
|
Lansdowne Developed Markets Long Only Master Fund Ltd
✚
|
L2 | |
|
IQ EQ Fund Management Ireland Ltd
✚
|
L2 | |
|
Gilead Therapeutics A1 Unlimited Co
✚
|
L2 | |
|
Dimensional Ireland Ltd
✚
|
L2 |